A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West Virginia ...

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...

Symbicort is an inhaler used for long-term control of asthma and COPD, but it is not a rescue inhaler. Before using Symbicort, tell your healthcare provider if you have health conditions like adrenal ...

Body says AstraZeneca breached code over misleading claim National guidelines for asthma treatment were different AstraZeneca disputes safety risk but updates website after complaint Oct 24 (Reuters) ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A U.S. flag stands next to the AstraZeneca logo during a signing event for documents related to a manufacturing site ...

Symbicort, which is used to treat chronic obstructive pulmonary disease and asthma, can cause side effects. Mild side effects include nasal congestion and headaches. Serious side effects include ...

William Smith is a flesh and blood writer who hasn't seen natural sunlight in months. He spends every waking hour at his laptop producing content to satisfy the cruel algorithm and to give those who ...

Lady Gaga raised the bar for all of pop stardom in one absolutely unforgettable breakout year. By Hilary Hughes (In 2018, the Billboard staff released a list project of its choices for the Greatest ...

President Joe Biden’s career-defining victories over Big Pharma — reforming Medicare to lower prices and capping inhaler costs for millions of Americans with lung disease — are facing an unlikely ...

We’ll never have another 2009 MTV Video Music Awards. From Lady Gaga’s game-changing performance of “Paparazzi” to Kanye West’s infamous interruption of Taylor Swift, the final MTV awards ceremony of ...

There's a lot of debate about how much signal to take from the 818,000 downward revisions to U.S. payrolls — the largest since 2009. Is it signaling recession? A few facts worth considering: By the ...

AstraZeneca, the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it plans to cap costs for patients using its inhalers in the U.S. at $35 per month starting June 1.